N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?
- PMID: 20507952
- PMCID: PMC2879314
- DOI: 10.2215/CJN.09001209
N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?
Abstract
Background and objectives: N-terminal probrain type natriuretic peptide (NTproBNP) has been proven to be a valuable biomarker for predicting cardiac events and mortality in the hemodialysis population. However recent reports have suggested that NTproBNP is a marker of volume overload rather than one of cardiac dysfunction. Therefore this study investigated the effect of fluid volume status on NTproBNP.
Design, setting, participants, & measurements: Volume status was determined pre- and postdialysis in 72 stable hemodialysis outpatients by multifrequency bioimpedance, and the relationship to NTproBNP values was examined.
Results: The mean and median NTproBNP values were 931.9 +/- 230 and 242 (90 to 688) pmol/L, respectively. On simple correlation, NTproBNP was associated with markers of volume overload and cardiac dysfunction. However, on logistical regression analysis, the strongest association was with the predialysis ratio of extracellular water/total body water (beta 26.6, F29.6, P = 0.000), followed by postdialysis mean arterial blood pressure (beta 0.14, F17.1, P = 0.000), dialysate calcium concentration (beta -1.19, F14.1, P = 0.002), and change in extracellular fluid volume with dialysis (beta 0.27, F7.4, P = 0.009)
Conclusions: In this study, NTproBNP was not associated with cardiac dysfunction as assessed by transthoracic echo or nuclear medicine scintigraphy but was dependent on factors associated with volume overload. However, because bioimpedance results can also be affected by malnutrition with loss of cell mass, NTproBNP may be elevated not only in patients with volume overload, but also those with malnutrition.
Figures
Comment in
-
BNP in hemodialysis patients.Clin J Am Soc Nephrol. 2010 Jun;5(6):954-5. doi: 10.2215/CJN.02710310. Epub 2010 May 27. Clin J Am Soc Nephrol. 2010. PMID: 20507956 No abstract available.
References
-
- Foley RN, Parfrey PS: Cardiovascular disease and mortality in ESRD. J Nephrol 11: 239–245, 1998 - PubMed
-
- David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D: Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis Nephrol Dial Transplant 23: 1370–1377, 2008 - PubMed
-
- Metry G, Hall C, Wilkstrom B, Kallskog V, Hansell P, Danielson B: Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography. Acta Physiol 171: 117–122, 2001 - PubMed
-
- Fagugli RM, Pasini P, Quintaliani G, Pasticici F, Cia G, Cicconi B, Ricciardi D, Santirosi PV, Buoncristiani E, Timio F, Valente F, Buoncristiani U: Association between brain natriuretic peptide and extracellular water in haemodialysis patients. Nephron Clin Pract 95: c60–c66, 2003 - PubMed
-
- Sheen V, Bhalla V, Tulua-Tata A, Bhalla MA, Weiss D, Chiu A, Abdeen O, Mullaney S, Maisel A. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. Am Heart J 153: 244.e1–e5, 2007 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous